Immucor (BLUD)

Operating income generated outside the United States as a percentage of total operating income was 11% in 2007, 10% in 2006 and 15% in 2005. In fiscal years 2007, 2006, and 2005, we recorded foreign currency translation gains of $1.1 million, $2.3 million and $0.6 million, respectively. During these years the foreign currency transaction gains were negligible. In fiscal 2007, a 7% increase compared to fiscal 2006 in the U.S.-Euro weighted average exchange rate increased net sales and net income by approximately $2.7 million and $0.2 million, respectively. In the case of the U.S. Dollar versus the Canadian Dollar, a 3% increase in fiscal 2007 compared to fiscal 2006 in the weighted average exchange rate increased net sales and net income by approximately $0.3 million and $0.1 million, respectively.

A 10% change in the year-to-date weighted average Euro exchange rate would have had the effect of increasing or decreasing net sales and net income by approximately $4.1 million and $0.3 million, respectively. A 10% change in the year-to-date weighted average Canadian Dollar exchange rate would

38

have had the effect of increasing or decreasing net sales and net income by approximately $1.1 million and $0.3 million, respectively.

Operating income generated outside the United States as a percentage of total operating income was 11% in 2007, 10% in 2006 and 15% in 2005. In fiscal years 2007, 2006, and 2005, we recorded foreign currency translation gains of $1.1 million, $2.3 million and $0.6 million, respectively. During these years the foreign currency transaction gains were negligible. In fiscal 2007, a 7% increase compared to fiscal 2006 in the U.S.-Euro weighted average exchange rate increased net sales and net income by approximately $2.7 million and $0.2 million, respectively. In the case of the U.S. Dollar versus the Canadian Dollar, a 3% increase in fiscal 2007 compared to fiscal 2006 in the weighted average exchange rate increased net sales and net income by approximately $0.3 million and $0.1 million, respectively.

A 10% change in the year-to-date weighted average Euro exchange rate would have had the effect of increasing or decreasing net sales and net income by approximately $4.1 million and $0.3 million, respectively. A 10% change in the year-to-date weighted average Canadian Dollar exchange rate would

38

have had the effect of increasing or decreasing net sales and net income by approximately $1.1 million and $0.3 million, respectively.

37

the Company’s new subsidiary which had financial instruments of approximately $3.2 million at May 31, 2006. Also, future payment obligations totaling $5.1 million related to the acquisition of Immucor-Kainos are denominated in Japanese Yen, and are therefore subject to foreign currency exchange risk. In 2006, 2005, and 2004, the Company recorded net foreign currency transaction gains of approximately $1,000, $0.5 million and $0.5 million, respectively; and foreign currency translation gains of $2.3 million, $0.6 million and $0.4 million, respectively. In fiscal 2006, a 5% decrease compared to fiscal 2005 in the U.S.-Euro weighted average exchange rate decreased net sales and net income by approximately $1.8 million and $0.1 million, respectively. A 10% change in the year-to-date weighted average Euro exchange rate would have had the effect of increasing or decreasing net sales and net income by approximately $3.6 million and $0.2 million, respectively. In case of U.S.-Canadian Dollar, a 7% increase in fiscal 2006 compared to fiscal 2005 in the weighted average exchange rate increased net sales and net income by approximately $0.7 million and $0.2 million, respectively. A 10% change in the year-to-date weighted average Canadian Dollar exchange rate would have had the effect of increasing or decreasing net sales and net income by approximately $1.0 million and $0.2 million, respectively.